



| Revenue | $100 - $500 million See Exact Annual Revenue |
|---|---|
| Employees | 100 - 500Exact Company Size |
| Primary Industry | 5417 Scientific Research & Development Services |
| Address | 40 Erie St Ste 110 Cambridge, MA 02139 |
| Biontech US | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $100 - $500 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Biontech US P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Date | Investors | Percent Raised | Target Size |
|---|---|---|---|
| December 13, 2017 | 25 | 100% | $106 MM |
| Complete list of funding rounds and total amounts in the Company Report | |||
| Trademark | Date |
|---|---|
| RECON BIOINFORMATICS ENGINE Medical and pharmaceutical consultation; providing information relating to therapeutic properties of pharmaceuticals | 12/04/2018 |
| NEO-STIM Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations; medical assays for testing of body fluids | 06/14/2018 |
| NEO STIM Medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals | 06/14/2018 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| LEIDOS | Denver, CO | 100 |
| NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
| INC RESEARCH | Raleigh, NC | 27 |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
| FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
| SYNEOS HEALTH | Raleigh, NC | 13 |
| ILLUMINA | San Diego, CA | 12 |
| UT-BATTELLE | Oak Ridge, TN | 11 |
| PRA HOLDINGS | Raleigh, NC | 11 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| BROAD INSTITUTE | Cambridge, MA | 100 |
| BEIGENE USA | Cambridge, MA | 69 |
| ALNYLAM PHARMACEUTICALS | Cambridge, MA | 52 |
| SAGE THERAPEUTICS | Cambridge, MA | 47 |
| INTELLIA THERAPEUTICS | Cambridge, MA | 35 |
| IPSEN BIOPHARMACEUTICALS | Cambridge, MA | 34 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |